The global Chronic Gout Treatment Drug market was valued at US$ 1203 million in 2023 and is anticipated to reach US$ 1635.6 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.

Chronic Gout Treatment Drug Market

Chronic gout is a metabolic disease often associated with high uric acid levels and the deposition of uric acid crystals. The main goals of chronic gout treatment medications are to reduce the symptoms of gout attacks, lower uric acid levels, and prevent the formation of uric acid crystals. As medicine advances, more and more research is focusing on personalized treatment, selecting the best treatment method based on the patient's genetic and physiological characteristics. Developments in pharmaceutical technology have made drug delivery more convenient and consistent, thereby improving treatment compliance.

This report aims to provide a comprehensive presentation of the global market for Chronic Gout Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Gout Treatment Drug.

Report Scope

The Chronic Gout Treatment Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Gout Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Gout Treatment Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chronic Gout Treatment Drug Market Report

Report Metric	Details
Report Name	Chronic Gout Treatment Drug Market
Accounted market size in 2023	US$ 1203 million
Forecasted market size in 2030	US$ 1635.6 million
CAGR	4.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Pill Capsule Others
Segment by Application	General Hospital Specialty Hospital Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GE Healthcare, AstraZeneca, Pfizer, Merck, Novartis, Takeda Pharmaceuticals, Sanofi, Boston Biomedical, Tianjin Kingyork Group, Atom Bioscience and Pharmaceutical, Wuhan Humanwell Pharmaceutical Group, Fosun Pharma, Chongqing Taiji Industry
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chronic Gout Treatment Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chronic Gout Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Chronic Gout Treatment Drug Market growing?

Ans: The Chronic Gout Treatment Drug Market witnessing a CAGR of 4.5% during the forecast period 2024-2030.

What is the Chronic Gout Treatment Drug Market size in 2030?

Ans: The Chronic Gout Treatment Drug Market size in 2030 will be US$ 1635.6 million.

Who are the main players in the Chronic Gout Treatment Drug Market report?

Ans: The main players in the Chronic Gout Treatment Drug Market are GE Healthcare, AstraZeneca, Pfizer, Merck, Novartis, Takeda Pharmaceuticals, Sanofi, Boston Biomedical, Tianjin Kingyork Group, Atom Bioscience and Pharmaceutical, Wuhan Humanwell Pharmaceutical Group, Fosun Pharma, Chongqing Taiji Industry

What are the Application segmentation covered in the Chronic Gout Treatment Drug Market report?

Ans: The Applications covered in the Chronic Gout Treatment Drug Market report are General Hospital, Specialty Hospital, Others

What are the Type segmentation covered in the Chronic Gout Treatment Drug Market report?

Ans: The Types covered in the Chronic Gout Treatment Drug Market report are Pill, Capsule, Others

1 Chronic Gout Treatment Drug Market Overview

1.1 Product Overview and Scope of Chronic Gout Treatment Drug

1.2 Chronic Gout Treatment Drug Segment by Type

1.2.1 Global Chronic Gout Treatment Drug Market Value Comparison by Type (2024-2030)

1.2.2 Pill

1.2.3 Capsule

1.2.4 Others

1.3 Chronic Gout Treatment Drug Segment by Application

1.3.1 Global Chronic Gout Treatment Drug Market Value by Application: (2024-2030)

1.3.2 General Hospital

1.3.3 Specialty Hospital

1.3.4 Others

1.4 Global Chronic Gout Treatment Drug Market Size Estimates and Forecasts

1.4.1 Global Chronic Gout Treatment Drug Revenue 2019-2030

1.4.2 Global Chronic Gout Treatment Drug Sales 2019-2030

1.4.3 Global Chronic Gout Treatment Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Chronic Gout Treatment Drug Market Competition by Manufacturers

2.1 Global Chronic Gout Treatment Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Chronic Gout Treatment Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Chronic Gout Treatment Drug Average Price by Manufacturers (2019-2024)

2.4 Global Chronic Gout Treatment Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Chronic Gout Treatment Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Chronic Gout Treatment Drug, Product Type & Application

2.7 Chronic Gout Treatment Drug Market Competitive Situation and Trends

2.7.1 Chronic Gout Treatment Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Chronic Gout Treatment Drug Players Market Share by Revenue

2.7.3 Global Chronic Gout Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Chronic Gout Treatment Drug Retrospective Market Scenario by Region

3.1 Global Chronic Gout Treatment Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Chronic Gout Treatment Drug Global Chronic Gout Treatment Drug Sales by Region: 2019-2030

3.2.1 Global Chronic Gout Treatment Drug Sales by Region: 2019-2024

3.2.2 Global Chronic Gout Treatment Drug Sales by Region: 2025-2030

3.3 Global Chronic Gout Treatment Drug Global Chronic Gout Treatment Drug Revenue by Region: 2019-2030

3.3.1 Global Chronic Gout Treatment Drug Revenue by Region: 2019-2024

3.3.2 Global Chronic Gout Treatment Drug Revenue by Region: 2025-2030

3.4 North America Chronic Gout Treatment Drug Market Facts & Figures by Country

3.4.1 North America Chronic Gout Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Chronic Gout Treatment Drug Sales by Country (2019-2030)

3.4.3 North America Chronic Gout Treatment Drug Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Chronic Gout Treatment Drug Market Facts & Figures by Country

3.5.1 Europe Chronic Gout Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Chronic Gout Treatment Drug Sales by Country (2019-2030)

3.5.3 Europe Chronic Gout Treatment Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Chronic Gout Treatment Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Chronic Gout Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Chronic Gout Treatment Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Chronic Gout Treatment Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Chronic Gout Treatment Drug Market Facts & Figures by Country

3.7.1 Latin America Chronic Gout Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Chronic Gout Treatment Drug Sales by Country (2019-2030)

3.7.3 Latin America Chronic Gout Treatment Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Chronic Gout Treatment Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Chronic Gout Treatment Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Chronic Gout Treatment Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Chronic Gout Treatment Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Chronic Gout Treatment Drug Sales by Type (2019-2030)

4.1.1 Global Chronic Gout Treatment Drug Sales by Type (2019-2024)

4.1.2 Global Chronic Gout Treatment Drug Sales by Type (2025-2030)

4.1.3 Global Chronic Gout Treatment Drug Sales Market Share by Type (2019-2030)

4.2 Global Chronic Gout Treatment Drug Revenue by Type (2019-2030)

4.2.1 Global Chronic Gout Treatment Drug Revenue by Type (2019-2024)

4.2.2 Global Chronic Gout Treatment Drug Revenue by Type (2025-2030)

4.2.3 Global Chronic Gout Treatment Drug Revenue Market Share by Type (2019-2030)

4.3 Global Chronic Gout Treatment Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Chronic Gout Treatment Drug Sales by Application (2019-2030)

5.1.1 Global Chronic Gout Treatment Drug Sales by Application (2019-2024)

5.1.2 Global Chronic Gout Treatment Drug Sales by Application (2025-2030)

5.1.3 Global Chronic Gout Treatment Drug Sales Market Share by Application (2019-2030)

5.2 Global Chronic Gout Treatment Drug Revenue by Application (2019-2030)

5.2.1 Global Chronic Gout Treatment Drug Revenue by Application (2019-2024)

5.2.2 Global Chronic Gout Treatment Drug Revenue by Application (2025-2030)

5.2.3 Global Chronic Gout Treatment Drug Revenue Market Share by Application (2019-2030)

5.3 Global Chronic Gout Treatment Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 GE Healthcare

6.1.1 GE Healthcare Corporation Information

6.1.2 GE Healthcare Description and Business Overview

6.1.3 GE Healthcare Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 GE Healthcare Chronic Gout Treatment Drug Product Portfolio

6.1.5 GE Healthcare Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Corporation Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AstraZeneca Chronic Gout Treatment Drug Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Corporation Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Pfizer Chronic Gout Treatment Drug Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Merck

6.4.1 Merck Corporation Information

6.4.2 Merck Description and Business Overview

6.4.3 Merck Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Merck Chronic Gout Treatment Drug Product Portfolio

6.4.5 Merck Recent Developments/Updates

6.5 Novartis

6.5.1 Novartis Corporation Information

6.5.2 Novartis Description and Business Overview

6.5.3 Novartis Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Novartis Chronic Gout Treatment Drug Product Portfolio

6.5.5 Novartis Recent Developments/Updates

6.6 Takeda Pharmaceuticals

6.6.1 Takeda Pharmaceuticals Corporation Information

6.6.2 Takeda Pharmaceuticals Description and Business Overview

6.6.3 Takeda Pharmaceuticals Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Takeda Pharmaceuticals Chronic Gout Treatment Drug Product Portfolio

6.6.5 Takeda Pharmaceuticals Recent Developments/Updates

6.7 Sanofi

6.6.1 Sanofi Corporation Information

6.6.2 Sanofi Description and Business Overview

6.6.3 Sanofi Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sanofi Chronic Gout Treatment Drug Product Portfolio

6.7.5 Sanofi Recent Developments/Updates

6.8 Boston Biomedical

6.8.1 Boston Biomedical Corporation Information

6.8.2 Boston Biomedical Description and Business Overview

6.8.3 Boston Biomedical Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Boston Biomedical Chronic Gout Treatment Drug Product Portfolio

6.8.5 Boston Biomedical Recent Developments/Updates

6.9 Tianjin Kingyork Group

6.9.1 Tianjin Kingyork Group Corporation Information

6.9.2 Tianjin Kingyork Group Description and Business Overview

6.9.3 Tianjin Kingyork Group Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Tianjin Kingyork Group Chronic Gout Treatment Drug Product Portfolio

6.9.5 Tianjin Kingyork Group Recent Developments/Updates

6.10 Atom Bioscience and Pharmaceutical

6.10.1 Atom Bioscience and Pharmaceutical Corporation Information

6.10.2 Atom Bioscience and Pharmaceutical Description and Business Overview

6.10.3 Atom Bioscience and Pharmaceutical Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Atom Bioscience and Pharmaceutical Chronic Gout Treatment Drug Product Portfolio

6.10.5 Atom Bioscience and Pharmaceutical Recent Developments/Updates

6.11 Wuhan Humanwell Pharmaceutical Group

6.11.1 Wuhan Humanwell Pharmaceutical Group Corporation Information

6.11.2 Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Description and Business Overview

6.11.3 Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Product Portfolio

6.11.5 Wuhan Humanwell Pharmaceutical Group Recent Developments/Updates

6.12 Fosun Pharma

6.12.1 Fosun Pharma Corporation Information

6.12.2 Fosun Pharma Chronic Gout Treatment Drug Description and Business Overview

6.12.3 Fosun Pharma Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Fosun Pharma Chronic Gout Treatment Drug Product Portfolio

6.12.5 Fosun Pharma Recent Developments/Updates

6.13 Chongqing Taiji Industry

6.13.1 Chongqing Taiji Industry Corporation Information

6.13.2 Chongqing Taiji Industry Chronic Gout Treatment Drug Description and Business Overview

6.13.3 Chongqing Taiji Industry Chronic Gout Treatment Drug Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Chongqing Taiji Industry Chronic Gout Treatment Drug Product Portfolio

6.13.5 Chongqing Taiji Industry Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Chronic Gout Treatment Drug Industry Chain Analysis

7.2 Chronic Gout Treatment Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Chronic Gout Treatment Drug Production Mode & Process

7.4 Chronic Gout Treatment Drug Sales and Marketing

7.4.1 Chronic Gout Treatment Drug Sales Channels

7.4.2 Chronic Gout Treatment Drug Distributors

7.5 Chronic Gout Treatment Drug Customers

8 Chronic Gout Treatment Drug Market Dynamics

8.1 Chronic Gout Treatment Drug Industry Trends

8.2 Chronic Gout Treatment Drug Market Drivers

8.3 Chronic Gout Treatment Drug Market Challenges

8.4 Chronic Gout Treatment Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceuticals

Sanofi

Boston Biomedical

TianJin KingYork Group

Fosun Pharma

Chongqing Taiji Industry

Atom Bioscience and Pharmaceutical

Wuhan Humanwell Pharmaceutical Group

List of Tables

Table 1. Global Chronic Gout Treatment Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Chronic Gout Treatment Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Chronic Gout Treatment Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Chronic Gout Treatment Drug Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Chronic Gout Treatment Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Chronic Gout Treatment Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Chronic Gout Treatment Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Chronic Gout Treatment Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Chronic Gout Treatment Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Chronic Gout Treatment Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Chronic Gout Treatment Drug, Product Type & Application

Table 12. Global Key Manufacturers of Chronic Gout Treatment Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Chronic Gout Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Gout Treatment Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Chronic Gout Treatment Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Chronic Gout Treatment Drug Sales by Region (2019-2024) & (K Units)

Table 18. Global Chronic Gout Treatment Drug Sales Market Share by Region (2019-2024)

Table 19. Global Chronic Gout Treatment Drug Sales by Region (2025-2030) & (K Units)

Table 20. Global Chronic Gout Treatment Drug Sales Market Share by Region (2025-2030)

Table 21. Global Chronic Gout Treatment Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Chronic Gout Treatment Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Chronic Gout Treatment Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Chronic Gout Treatment Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Chronic Gout Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Chronic Gout Treatment Drug Sales by Country (2019-2024) & (K Units)

Table 27. North America Chronic Gout Treatment Drug Sales by Country (2025-2030) & (K Units)

Table 28. North America Chronic Gout Treatment Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Chronic Gout Treatment Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Chronic Gout Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Chronic Gout Treatment Drug Sales by Country (2019-2024) & (K Units)

Table 32. Europe Chronic Gout Treatment Drug Sales by Country (2025-2030) & (K Units)

Table 33. Europe Chronic Gout Treatment Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Chronic Gout Treatment Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Chronic Gout Treatment Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Chronic Gout Treatment Drug Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Chronic Gout Treatment Drug Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Chronic Gout Treatment Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Chronic Gout Treatment Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Chronic Gout Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Chronic Gout Treatment Drug Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Chronic Gout Treatment Drug Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Chronic Gout Treatment Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Chronic Gout Treatment Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Chronic Gout Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Chronic Gout Treatment Drug Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Chronic Gout Treatment Drug Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Chronic Gout Treatment Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Chronic Gout Treatment Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Chronic Gout Treatment Drug Sales (K Units) by Type (2019-2024)

Table 51. Global Chronic Gout Treatment Drug Sales (K Units) by Type (2025-2030)

Table 52. Global Chronic Gout Treatment Drug Sales Market Share by Type (2019-2024)

Table 53. Global Chronic Gout Treatment Drug Sales Market Share by Type (2025-2030)

Table 54. Global Chronic Gout Treatment Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Chronic Gout Treatment Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Chronic Gout Treatment Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Chronic Gout Treatment Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Chronic Gout Treatment Drug Price (US$/Unit) by Type (2019-2024)

Table 59. Global Chronic Gout Treatment Drug Price (US$/Unit) by Type (2025-2030)

Table 60. Global Chronic Gout Treatment Drug Sales (K Units) by Application (2019-2024)

Table 61. Global Chronic Gout Treatment Drug Sales (K Units) by Application (2025-2030)

Table 62. Global Chronic Gout Treatment Drug Sales Market Share by Application (2019-2024)

Table 63. Global Chronic Gout Treatment Drug Sales Market Share by Application (2025-2030)

Table 64. Global Chronic Gout Treatment Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Chronic Gout Treatment Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Chronic Gout Treatment Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Chronic Gout Treatment Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Chronic Gout Treatment Drug Price (US$/Unit) by Application (2019-2024)

Table 69. Global Chronic Gout Treatment Drug Price (US$/Unit) by Application (2025-2030)

Table 70. GE Healthcare Corporation Information

Table 71. GE Healthcare Description and Business Overview

Table 72. GE Healthcare Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. GE Healthcare Chronic Gout Treatment Drug Product

Table 74. GE Healthcare Recent Developments/Updates

Table 75. AstraZeneca Corporation Information

Table 76. AstraZeneca Description and Business Overview

Table 77. AstraZeneca Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. AstraZeneca Chronic Gout Treatment Drug Product

Table 79. AstraZeneca Recent Developments/Updates

Table 80. Pfizer Corporation Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Pfizer Chronic Gout Treatment Drug Product

Table 84. Pfizer Recent Developments/Updates

Table 85. Merck Corporation Information

Table 86. Merck Description and Business Overview

Table 87. Merck Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Merck Chronic Gout Treatment Drug Product

Table 89. Merck Recent Developments/Updates

Table 90. Novartis Corporation Information

Table 91. Novartis Description and Business Overview

Table 92. Novartis Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Novartis Chronic Gout Treatment Drug Product

Table 94. Novartis Recent Developments/Updates

Table 95. Takeda Pharmaceuticals Corporation Information

Table 96. Takeda Pharmaceuticals Description and Business Overview

Table 97. Takeda Pharmaceuticals Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Takeda Pharmaceuticals Chronic Gout Treatment Drug Product

Table 99. Takeda Pharmaceuticals Recent Developments/Updates

Table 100. Sanofi Corporation Information

Table 101. Sanofi Description and Business Overview

Table 102. Sanofi Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Sanofi Chronic Gout Treatment Drug Product

Table 104. Sanofi Recent Developments/Updates

Table 105. Boston Biomedical Corporation Information

Table 106. Boston Biomedical Description and Business Overview

Table 107. Boston Biomedical Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Boston Biomedical Chronic Gout Treatment Drug Product

Table 109. Boston Biomedical Recent Developments/Updates

Table 110. Tianjin Kingyork Group Corporation Information

Table 111. Tianjin Kingyork Group Description and Business Overview

Table 112. Tianjin Kingyork Group Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Tianjin Kingyork Group Chronic Gout Treatment Drug Product

Table 114. Tianjin Kingyork Group Recent Developments/Updates

Table 115. Atom Bioscience and Pharmaceutical Corporation Information

Table 116. Atom Bioscience and Pharmaceutical Description and Business Overview

Table 117. Atom Bioscience and Pharmaceutical Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Atom Bioscience and Pharmaceutical Chronic Gout Treatment Drug Product

Table 119. Atom Bioscience and Pharmaceutical Recent Developments/Updates

Table 120. Wuhan Humanwell Pharmaceutical Group Corporation Information

Table 121. Wuhan Humanwell Pharmaceutical Group Description and Business Overview

Table 122. Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Wuhan Humanwell Pharmaceutical Group Chronic Gout Treatment Drug Product

Table 124. Wuhan Humanwell Pharmaceutical Group Recent Developments/Updates

Table 125. Fosun Pharma Corporation Information

Table 126. Fosun Pharma Description and Business Overview

Table 127. Fosun Pharma Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Fosun Pharma Chronic Gout Treatment Drug Product

Table 129. Fosun Pharma Recent Developments/Updates

Table 130. Chongqing Taiji Industry Corporation Information

Table 131. Chongqing Taiji Industry Description and Business Overview

Table 132. Chongqing Taiji Industry Chronic Gout Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Chongqing Taiji Industry Chronic Gout Treatment Drug Product

Table 134. Chongqing Taiji Industry Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Chronic Gout Treatment Drug Distributors List

Table 138. Chronic Gout Treatment Drug Customers List

Table 139. Chronic Gout Treatment Drug Market Trends

Table 140. Chronic Gout Treatment Drug Market Drivers

Table 141. Chronic Gout Treatment Drug Market Challenges

Table 142. Chronic Gout Treatment Drug Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Chronic Gout Treatment Drug

Figure 2. Global Chronic Gout Treatment Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Chronic Gout Treatment Drug Market Share by Type in 2023 & 2030

Figure 4. Pill Product Picture

Figure 5. Capsule Product Picture

Figure 6. Others Product Picture

Figure 7. Global Chronic Gout Treatment Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Chronic Gout Treatment Drug Market Share by Application in 2023 & 2030

Figure 9. General Hospital

Figure 10. Specialty Hospital

Figure 11. Others

Figure 12. Global Chronic Gout Treatment Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Chronic Gout Treatment Drug Market Size (2019-2030) & (US$ Million)

Figure 14. Global Chronic Gout Treatment Drug Sales (2019-2030) & (K Units)

Figure 15. Global Chronic Gout Treatment Drug Average Price (US$/Unit) & (2019-2030)

Figure 16. Chronic Gout Treatment Drug Report Years Considered

Figure 17. Chronic Gout Treatment Drug Sales Share by Manufacturers in 2023

Figure 18. Global Chronic Gout Treatment Drug Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Chronic Gout Treatment Drug Players: Market Share by Revenue in 2023

Figure 20. Chronic Gout Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Chronic Gout Treatment Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Chronic Gout Treatment Drug Sales Market Share by Country (2019-2030)

Figure 23. North America Chronic Gout Treatment Drug Revenue Market Share by Country (2019-2030)

Figure 24. United States Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Chronic Gout Treatment Drug Sales Market Share by Country (2019-2030)

Figure 27. Europe Chronic Gout Treatment Drug Revenue Market Share by Country (2019-2030)

Figure 28. Germany Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Chronic Gout Treatment Drug Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Chronic Gout Treatment Drug Revenue Market Share by Region (2019-2030)

Figure 35. China Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Chronic Gout Treatment Drug Sales Market Share by Country (2019-2030)

Figure 43. Latin America Chronic Gout Treatment Drug Revenue Market Share by Country (2019-2030)

Figure 44. Mexico Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Chronic Gout Treatment Drug Sales Market Share by Country (2019-2030)

Figure 48. Middle East & Africa Chronic Gout Treatment Drug Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Chronic Gout Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Chronic Gout Treatment Drug by Type (2019-2030)

Figure 53. Global Revenue Market Share of Chronic Gout Treatment Drug by Type (2019-2030)

Figure 54. Global Chronic Gout Treatment Drug Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Chronic Gout Treatment Drug by Application (2019-2030)

Figure 56. Global Revenue Market Share of Chronic Gout Treatment Drug by Application (2019-2030)

Figure 57. Global Chronic Gout Treatment Drug Price (US$/Unit) by Application (2019-2030)

Figure 58. Chronic Gout Treatment Drug Value Chain

Figure 59. Chronic Gout Treatment Drug Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Distributors Profiles

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Chronic Gout Treatment Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24Y15383

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Anti Cyclic Citrullinated Peptide(Anti-CCP) Antibody Assay Kit Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-28X14149

Wed Aug 14 00:00:00 UTC 2024

Add to Cart

Global Rheumatoid Arthritis Testing Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-33E11182

Tue Aug 06 00:00:00 UTC 2024

Add to Cart

Global Rheumatic Disorders Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-15X13281

Thu Jul 25 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions